The stained sections were examined under a trinocular light microscope (Leica DM500), and photomicrographs were captured using a digital camera (Leica EC3
Un editorial (en ingls) que acompa el informe del 24 de noviembre de JAMA Internal Medicine dice que los populares GLP-1 necesitan ser rebautizados de medicamentos para "prdida de peso" a medicamentos para "manejo de peso" ya que algunas personas podran necesitar tomarlos indefinidamente
It is not intended as medical advice and should not be used to diagnose, treat, cure, or prevent any disease or medical condition
Heres what we know and dont know: Most cases were described as mild and did not lead to stopping the drug Its not seen with semaglutide or tirzepatide it may be related to glucagon receptor activation, but this isnt confirmed The Phase 2 trial did note altered or enhanced skin sensation at lower rates, so it may not be entirely new just more apparent at scale It needs investigation across the remaining 7 Phase 3 trials reporting in 2026 Is it a dealbreaker
Whether its increased energy, faster fat breakdown, or overall wellness, you can trust that well help you achieve your weight loss goals
The clinical literature on erythromycin for gastroparesis supports short-term use, but tachyphylaxis (loss of effect) develops within 4 weeks in many patients